Structural Biology Center
Using high-powered X-rays and Argonne-developed X-ray detectors,
researchers at Argonne's Structural Biology Center study data on disease
processes and potential cures hundreds of times faster than previously
possible. Information gathered at the center helps in the design of
vaccines and virus- and bacteria-killing pharmaceuticals.
One Argonne research effort determined the structure of the cholera
toxin and how it is able to attack the body. Such knowledge may lead to an
improved vaccine.
The center's board of directors includes many of the world's leading
molecular biologists. Employing a technique called X-ray protein
crystallography, researchers use the center's facilities to find all of
the thousands of atoms that make up viruses, proteins, enzymes and other
large biological molecules important to human health. The center is used
for applied research into medicine, industrial enzymes and other
biotechnology products, and for basic research in structural and molecular
biology.
Center facilities are available to all qualified biologists through
peer-reviewed proposals. As many as 250 biological and medical researchers
can use the facility each year. In X-ray protein crystallography,
scientists grow crystals of viruses or bacterial proteins the size of a
salt grain and then bounce - or diffract - X-rays off the crystals.
Computers transform two-dimensional X-ray diffraction patterns into
three-dimensional figures revealing details about molecular structure at
atomic resolution and providing clues to viral, bacterial and molecular
function. Such knowledge at the molecular level allows the design of
better enzymes and molecular processes and allows pharmaceutical
development to combat viral and bacterial disease. The center is a
$15-million research facility at Argonne's Advanced Photon Source.
For more information about Argonne's Structural Biology Center, visit
the Web site of Argonne's Structural
Biology Center.
|